Mary Riley
General CounselExpecting more out of medicine
We are a clinical-stage biopharmaceutical company combining innovative chemistry with well-validated biology to make medicines more accessible for people living with chronic autoimmune and inflammatory diseases.
We are led by an exceptional team of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization.
